Diagnostics

September 12, 2018

The Future of BioManufacturing: Automated Closed Systems for Cell & Gene Therapy Processes

August 10, 2018
Democratising DNA: 23andMe & GSK Collaboration Raises Privacy & Data Quality Concerns - Can Blockchain Offer a Disruptive Solution?

Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?

[vc_row][vc_column][vc_column_text] Personal genomics company 23andMe recently entered a four-year $500M collaborative agreement with major pharmaceutical company GlaxoSmithKline. The deal gives GSK access to the genetic data […]
June 4, 2018

The Future of BioManufacturing: In Silico Modelling

March 27, 2018

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

[vc_row][vc_column][vc_column_text] Oxford Nanopore recently announced that it has attracted a further £100M in funding. The latest investment round values Oxford Nanopore at £1.5B, with Singapore-based GIC, […]
December 8, 2017

The Future of BioManufacturing: Downstream Processing

September 26, 2017

The Future of BioManufacturing: Cell Line Engineering

August 25, 2017

The Future of BioManufacturing: The Promise of Perfusion

July 24, 2017

The Future of BioManufacturing: Reduction in Market Scale Quantities

July 14, 2017

Looking Beyond Genomics: A Holistic Approach to Precision Medicine

[vc_row][vc_column][vc_column_text] England’s Chief Medical Officer, Dame Sally Davies, recently called for making genomic testing as common as blood tests in order to usher in the era […]
Contact Us